Catheter Precision Reports Q1 Revenue Growth of 200% Year-Over-Year
Catheter Precision (VTAK:NYSE) reported a significant year-over-year revenue increase in the first quarter, with $432,000 compared to $143,000 in Q1 2025. The growth was attributed to strong performance across its core medical device segment and new aviation platform. Additionally, the company reduced its net loss from $4.0 million to $1.7 million.
Tickers: $VTAK
Topics: net_loss_reduction revenue_growth